Literature DB >> 35545877

Rapid identification of human muscle disease with fibre optic Raman spectroscopy.

James J P Alix1,2, Maria Plesia1, Gavin R Lloyd3, Alexander P Dudgeon4,5, Catherine A Kendall4, Channa Hewamadduma1,2,6, Marios Hadjivassiliou6, Christopher J McDermott1,2, Gráinne S Gorman7,8, Robert W Taylor7,8, Pamela J Shaw1,2, John C C Day9.   

Abstract

The diagnosis of muscle disorders ("myopathies") can be challenging and new biomarkers of disease are required to enhance clinical practice and research. Despite advances in areas such as imaging and genomic medicine, muscle biopsy remains an important but time-consuming investigation. Raman spectroscopy is a vibrational spectroscopy application that could provide a rapid analysis of muscle tissue, as it requires no sample preparation and is simple to perform. Here, we investigated the feasibility of using a miniaturised, portable fibre optic Raman system for the rapid identification of muscle disease. Samples were assessed from 27 patients with a final clinico-pathological diagnosis of a myopathy and 17 patients in whom investigations and clinical follow-up excluded myopathy. Multivariate classification techniques achieved accuracies ranging between 71-77%. To explore the potential of Raman spectroscopy to identify different myopathies, patients were subdivided into mitochondrial and non-mitochondrial myopathy groups. Classification accuracies were between 74-89%. Observed spectral changes were related to changes in protein structure. These data indicate fibre optic Raman spectroscopy is a promising technique for the rapid identification of muscle disease that could provide real time diagnostic information. The application of fibre optic Raman technology raises the prospect of in vivo bedside testing for muscle diseases which would significantly streamline the diagnostic pathway of these disorders.

Entities:  

Mesh:

Year:  2022        PMID: 35545877      PMCID: PMC9150427          DOI: 10.1039/d1an01932e

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   5.227


  34 in total

1.  Baseline correction using adaptive iteratively reweighted penalized least squares.

Authors:  Zhi-Min Zhang; Shan Chen; Yi-Zeng Liang
Journal:  Analyst       Date:  2010-02-19       Impact factor: 4.616

2.  Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies.

Authors:  Damien Bachasson; Océane Landon-Cardinal; Olivier Benveniste; Jean-Yves Hogrel; Yves Allenbach
Journal:  Neurology       Date:  2017-05-31       Impact factor: 9.910

Review 3.  Developing fibre optic Raman probes for applications in clinical spectroscopy.

Authors:  Oliver Stevens; Ingeborg E Iping Petterson; John C C Day; Nick Stone
Journal:  Chem Soc Rev       Date:  2016-03-09       Impact factor: 54.564

4.  Using Raman spectroscopy to characterize biological materials.

Authors:  Holly J Butler; Lorna Ashton; Benjamin Bird; Gianfelice Cinque; Kelly Curtis; Jennifer Dorney; Karen Esmonde-White; Nigel J Fullwood; Benjamin Gardner; Pierre L Martin-Hirsch; Michael J Walsh; Martin R McAinsh; Nicholas Stone; Francis L Martin
Journal:  Nat Protoc       Date:  2016-03-10       Impact factor: 13.491

5.  Healthcare costs of inflammatory myopathies.

Authors:  Sasha Bernatsky; Pantelis Panopalis; Christian A Pineau; Marie Hudson; Yvan St Pierre; Ann E Clarke
Journal:  J Rheumatol       Date:  2011-03-01       Impact factor: 4.666

Review 6.  Muscular dystrophies.

Authors:  Eugenio Mercuri; Carsten G Bönnemann; Francesco Muntoni
Journal:  Lancet       Date:  2019-11-30       Impact factor: 79.321

Review 7.  Mitochondrial Diseases: A Diagnostic Revolution.

Authors:  Katherine R Schon; Thiloka Ratnaike; Jelle van den Ameele; Rita Horvath; Patrick F Chinnery
Journal:  Trends Genet       Date:  2020-07-13       Impact factor: 11.639

8.  In Vivo Fiber Optic Raman Spectroscopy of Muscle in Preclinical Models of Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy.

Authors:  Maria Plesia; Oliver A Stevens; Gavin R Lloyd; Catherine A Kendall; Ian Coldicott; Aneurin J Kennerley; Gaynor Miller; Pamela J Shaw; Richard J Mead; John C C Day; James J P Alix
Journal:  ACS Chem Neurosci       Date:  2021-05-05       Impact factor: 4.418

9.  Delay in diagnosis of muscle disorders depends on the subspecialty of the initially consulted physician.

Authors:  Simone Spuler; Andrea Stroux; Franziska Kuschel; Adelheid Kuhlmey; Friederike Kendel
Journal:  BMC Health Serv Res       Date:  2011-05-04       Impact factor: 2.655

10.  Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease.

Authors:  Anna Huefner; Wei-Li Kuan; Sarah L Mason; Sumeet Mahajan; Roger A Barker
Journal:  Chem Sci       Date:  2019-11-14       Impact factor: 9.825

View more
  1 in total

1.  Fiber optic Raman spectroscopy for the evaluation of disease state in Duchenne muscular dystrophy: An assessment using the mdx model and human muscle.

Authors:  James J P Alix; Maria Plesia; Sarah A Hool; Ian Coldicott; Catherine A Kendall; Pamela J Shaw Dbe; Richard J Mead; John C Day
Journal:  Muscle Nerve       Date:  2022-07-15       Impact factor: 3.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.